News & Events
Researchers identify a key enzyme in tumours
Researchers have identified a key enzyme that cancerous tumours rely on to grow and spread within the body. Described…
ctDNA accurate at diagnosing rectal cancer relapse
Combining circulating tumour DNA (ctDNA) with magnetic resonance imaging (MRI) can more accurately predict the likelihood of locally advanced…
Measuring circulating tumour DNA can improve bladder cancer treatment
The presence of circulating tumour DNA (ctDNA) is a crucial biomarker for patients with bladder cancer (urothelial carcinoma) researchers…
Promising new immunotherapy for colorectal cancer patients
Patients with advanced colorectal cancer can benefit from treatment with advanced immunotherapy, known as immune checkpoint inhibitor PD-1/PD-L1, scientists…
New breast cancer therapy a step closer to clinical trials
An advanced cancer therapy developed by RGCC scientists has been categorised as a Cell Therapy Medicinal Product (CTMP) by the European…
Activating p53 protein improves cancer-killing potential
Activating protein p53 can boost a patient's immune response against cancerous tumours, researchers at Sweden's Karolinska Institutet have discovered.…
RGCC scientists develop novel new approach to inhibiting SARS-COV-2 replication
RGCC researchers have developed a new approach to tackling COVID-19 (SARS-CoV-2) that could form the basis of a new…
New cancer vaccine effective in 75% of tumours
A new cancer vaccine is 75% effective at eliminating cancerous tumours in mice, say scientists at the University of…
New blood test can diagnose cancer without tumour sample
US scientists have developed the world's first 'tumour-uninformed' test that can detect cancer DNA circulating in the blood of…
New Genistein capsule offers improved cancer-killing properties
RGCC scientists have developed a new anti-cancer dietary supplement that’s 34% more effective than the leading brand. Led by…
Personalised cancer vaccine 45% effective at targeting tumours
Researchers have developed an effective vaccine that re-engineers cells from a patient’s tumour to target and destroy cancer cells.…
Scientists farm natural “cancer-killing” exomes
US researchers have developed the first systemic way to catch and release cancer-killing packets, called exomes. Thousands of times…